Annual SG&A
$8.02 M
-$2.58 M-24.35%
01 December 2023
Summary:
Addex Therapeutics Ltd annual selling, general & administrative expenses is currently $8.02 million, with the most recent change of -$2.58 million (-24.35%) on 01 December 2023. During the last 3 years, it has risen by +$1.89 million (+30.84%). ADXN annual SG&A is now -59.48% below its all-time high of $19.80 million, reached on 31 December 2011.ADXN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$560.80 K
-$93.40 K-14.28%
01 June 2024
Summary:
Addex Therapeutics Ltd quarterly selling, general & administrative expenses is currently $560.80 thousand, with the most recent change of -$93.40 thousand (-14.28%) on 01 June 2024. Over the past year, it has dropped by -$1.42 million (-71.70%). ADXN quarterly SG&A is now -83.01% below its all-time high of $3.30 million, reached on 31 March 2022.ADXN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.61 B
+$4.66 M+0.29%
01 June 2024
Summary:
Addex Therapeutics Ltd TTM selling, general & administrative expenses is currently -$1.61 billion, with the most recent change of +$4.66 million (+0.29%) on 01 June 2024. Over the past year, it has dropped by -$1.62 billion (-27608.03%). ADXN TTM SG&A is now -916.64% below its all-time high of $10.63 million, reached on 31 December 2022.ADXN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADXN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.4% | -71.7% | -10000.0% |
| 3 y3 years | +30.8% | -74.9% | -10000.0% |
| 5 y5 years | +181.2% | -68.7% | -10000.0% |
ADXN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -24.4% | +30.8% | -83.0% | +2.9% | -16.0% | +0.3% |
| 5 y | 5 years | -24.4% | +181.2% | -83.0% | +173.5% | -163.9% | +0.3% |
| alltime | all time | -59.5% | +858.1% | -83.0% | +173.5% | -916.6% | +0.3% |
Addex Therapeutics Ltd Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $560.80 K(-14.3%) | $5.12 M(-1.9%) |
| Mar 2024 | - | $654.20 K(-66.0%) | $5.22 M(+2.1%) |
| Dec 2023 | $8.02 M(-24.4%) | $1.92 M(-3.0%) | $5.11 M(-12.9%) |
| Sept 2023 | - | $1.98 M(+200.3%) | $5.86 M(-7.8%) |
| June 2023 | - | $659.80 K(+21.1%) | $6.36 M(-19.3%) |
| Mar 2023 | - | $545.00 K(-79.6%) | $7.87 M(-25.9%) |
| Dec 2022 | $10.61 M(+25.1%) | $2.68 M(+8.2%) | $10.63 M(+7.4%) |
| Sept 2022 | - | $2.47 M(+13.6%) | $9.89 M(+2.5%) |
| June 2022 | - | $2.18 M(-34.0%) | $9.66 M(+1.6%) |
| Mar 2022 | - | $3.30 M(+70.1%) | $9.50 M(+24.0%) |
| Dec 2021 | $8.48 M(+38.2%) | $1.94 M(-13.3%) | $7.67 M(+7.8%) |
| Sept 2021 | - | $2.24 M(+10.3%) | $7.11 M(+14.3%) |
| June 2021 | - | $2.03 M(+38.7%) | $6.22 M(+6.5%) |
| Mar 2021 | - | $1.46 M(+5.5%) | $5.84 M(-4.4%) |
| Dec 2020 | $6.13 M | $1.39 M(+3.1%) | $6.11 M(+54.3%) |
| Sept 2020 | - | $1.34 M(-18.3%) | $3.96 M(-10.2%) |
| June 2020 | - | $1.65 M(-4.7%) | $4.41 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $1.73 M(-326.5%) | $4.23 M(+5.6%) |
| Dec 2019 | $4.34 M(+52.0%) | -$763.00 K(-142.6%) | $4.01 M(-16.0%) |
| Sept 2019 | - | $1.79 M(+21.6%) | $4.77 M(+60.2%) |
| June 2019 | - | $1.47 M(-2.0%) | $2.98 M(+98.0%) |
| Mar 2019 | - | $1.50 M | $1.50 M |
| Dec 2018 | $2.85 M(+240.7%) | - | - |
| Dec 2017 | $837.50 K(-45.8%) | - | - |
| Dec 2016 | $1.55 M(-5.1%) | - | - |
| Dec 2015 | $1.63 M(-3.8%) | - | - |
| Dec 2014 | $1.69 M(-79.7%) | - | - |
| Dec 2013 | $8.35 M(-37.1%) | - | - |
| Dec 2012 | $13.27 M(-33.0%) | - | - |
| Dec 2011 | $19.80 M(+222.2%) | - | - |
| Dec 2010 | $6.14 M(-12.4%) | - | - |
| Dec 2009 | $7.02 M(+0.3%) | - | - |
| Dec 2008 | $6.99 M(-22.1%) | - | - |
| Dec 2007 | $8.98 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual SG&A year-on-year change?
- What is Addex Therapeutics Ltd quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly SG&A year-on-year change?
- What is Addex Therapeutics Ltd TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM SG&A year-on-year change?
What is Addex Therapeutics Ltd annual selling, general & administrative expenses?
The current annual SG&A of ADXN is $8.02 M
What is the all time high annual SG&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual selling, general & administrative expenses is $19.80 M
What is Addex Therapeutics Ltd annual SG&A year-on-year change?
Over the past year, ADXN annual selling, general & administrative expenses has changed by -$2.58 M (-24.35%)
What is Addex Therapeutics Ltd quarterly selling, general & administrative expenses?
The current quarterly SG&A of ADXN is $560.80 K
What is the all time high quarterly SG&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly selling, general & administrative expenses is $3.30 M
What is Addex Therapeutics Ltd quarterly SG&A year-on-year change?
Over the past year, ADXN quarterly selling, general & administrative expenses has changed by -$1.42 M (-71.70%)
What is Addex Therapeutics Ltd TTM selling, general & administrative expenses?
The current TTM SG&A of ADXN is -$1.61 B
What is the all time high TTM SG&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM selling, general & administrative expenses is $10.63 M
What is Addex Therapeutics Ltd TTM SG&A year-on-year change?
Over the past year, ADXN TTM selling, general & administrative expenses has changed by -$1.62 B (-27608.03%)